Compounds > bucladesine

bucladesine and Prostatic Neoplasms

bucladesine has been researched along with Prostatic Neoplasms in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (53.33)18.2507
2000's5 (33.33)29.6817
2010's2 (13.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asano, E; Fukami, K; Kawabata, A; Sekiguchi, F; Ueda, M; Yoshida, S1
Cantile, M; Chieffi, P; Cillo, C; Fabbrocini, G; Kisslinger, A; Mancini, FP; Sparaneo, G; Tramontano, D; Vitale, N1
Desiniotis, A; Eder, IE; Klocker, H; Schäfer, G1
Altieri, V; Cantile, M; Cillo, C; Cindolo, L; D'Antò, V; Franco, R; Gallo, A; Kisslinger, A; Schiavo, G; Tramontano, D; Villacci, A1
Chung, LW; Hoosein, NM; Logothetis, CJ1
Andrade, AA; Ashby, MH; Gkonos, PJ1
Bartsch, G; Cronauer, MV; Culig, Z; Hittmair, A; Hobisch, A; Klocker, H; Radmayr, C; Zhang, J1
Carraway, RE; Mitra, SP1
Cox, ME; Deeble, PD; Lakhani, S; Parsons, SJ1
De Luca, C; Di Carlo, A; Macchia, V; Mariano, A1
Kondrikov, D; Lin, MF; Moore, C; Taylor, R; Verni, M; Zelivianski, S1
Chieffi, P; Dikic, I; Kisslinger, A; Picascia, A; Stanzione, R; Tramontano, D1
Baarends, WM; Blok, LJ; Grootegoed, JA; Hoogerbrugge, JW; Peters, AH; Themmen, AP; Trapman, J1
Bang, YJ; Danielpour, D; Kim, KY; Kim, SJ; Myers, CE; O'Reilly, MA; Trepel, JB1
Kagawa, Y; Nishi, N; Okutani, T; Takasuga, H; Takenaka, I; Usui, T; Wada, F1

Other Studies

15 other study(ies) available for bucladesine and Prostatic Neoplasms

ArticleYear
High glucose induces N-linked glycosylation-mediated functional upregulation and overexpression of Ca
    Journal of pharmacological sciences, 2017, Volume: 133, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Bucladesine; Calcium Channels, T-Type; Cell Differentiation; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glucose; Glycosylation; Humans; Male; Membrane Potentials; Prostatic Neoplasms; Tunicamycin; Up-Regulation

2017
cAMP and Pyk2 interact to regulate prostate cell proliferation and function.
    Cancer biology & therapy, 2009, Volume: 8, Issue:3

    Topics: Bucladesine; Cell Line, Tumor; Cell Proliferation; Focal Adhesion Kinase 2; Gene Expression Regulation, Neoplastic; Genes, Homeobox; Humans; Lysophospholipids; Male; Mitogen-Activated Protein Kinase 1; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction

2009
Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A.
    International journal of cancer, 2010, Feb-01, Volume: 126, Issue:3

    Topics: Adenocarcinoma; Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Animals; Apoptosis; Bucladesine; Cell Division; Colforsin; Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; Enzyme Induction; Gene Knockdown Techniques; Humans; Isoquinolines; Male; Metribolone; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nitriles; Prostatic Neoplasms; Receptors, Androgen; RNA, Small Interfering; Signal Transduction; Sulfonamides; Tosyl Compounds

2010
cAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers.
    Journal of cellular physiology, 2005, Volume: 205, Issue:2

    Topics: Bucladesine; Cell Culture Techniques; Cell Differentiation; Cell Line; Cell Line, Tumor; Chromosome Mapping; Chromosomes, Human, Pair 2; Disease Progression; Gene Expression; Genes, Homeobox; Homeodomain Proteins; Humans; Immunohistochemistry; Male; Neurosecretory Systems; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction

2005
Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells.
    The Journal of urology, 1993, Volume: 149, Issue:5

    Topics: Adenylyl Cyclases; Bombesin; Bucladesine; Cell Division; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Somatostatin; Tumor Cells, Cultured; Vasoactive Intestinal Peptide

1993
Vasoactive intestinal peptide stimulates prostate-specific antigen secretion by LNCaP prostate cancer cells.
    Regulatory peptides, 1996, Sep-09, Volume: 65, Issue:2

    Topics: Bucladesine; Dose-Response Relationship, Drug; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Messenger; Tumor Cells, Cultured; Vasoactive Intestinal Peptide

1996
Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cells.
    The Prostate, 1997, Jul-01, Volume: 32, Issue:2

    Topics: Androgen Antagonists; Anilides; Bucladesine; Cell Line; Chloramphenicol O-Acetyltransferase; Cyclic AMP; Flutamide; Genes, Reporter; Gonadotropin-Releasing Hormone; Humans; Kinetics; Male; Metribolone; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Recombinant Fusion Proteins; Testosterone Congeners; Tosyl Compounds; Transcriptional Activation; Transfection; Tumor Cells, Cultured

1997
Synergistic effects of neurotensin and beta-adrenergic agonist on 3,5-cyclic adenosine monophosphate accumulation and DNA synthesis in prostate cancer PC3 cells.
    Biochemical pharmacology, 1999, Jun-15, Volume: 57, Issue:12

    Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Bucladesine; Cell Division; Cyclic AMP; DNA; Dose-Response Relationship, Drug; Drug Synergism; Humans; Isoproterenol; Male; Neurotensin; Phosphodiesterase Inhibitors; Prostatic Neoplasms; Receptors, Adrenergic, beta; Receptors, Neurotensin; Theophylline; Tumor Cells, Cultured

1999
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
    Cancer research, 1999, Aug-01, Volume: 59, Issue:15

    Topics: 1-Methyl-3-isobutylxanthine; Adenocarcinoma; Androgens; Biomarkers; Bombesin; Bucladesine; Calcium-Calmodulin-Dependent Protein Kinases; Cell Differentiation; Cell Division; Cell Lineage; Chromogranin A; Chromogranins; Colforsin; Cyclic AMP; Cytoplasmic Granules; Dihydrotestosterone; Disease Progression; Epinephrine; Humans; Isoproterenol; Male; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neoplastic Stem Cells; Neuroendocrine Tumors; Neurotensin; Parathyroid Hormone-Related Protein; Phenotype; Phosphopyruvate Hydratase; Prostatic Neoplasms; Protein-Tyrosine Kinases; Proteins; Second Messenger Systems; Serotonin; Tumor Cells, Cultured

1999
Effects of cyclic adenosine-monophosphate on growth and PSA secretion of human prostate cancer cell line.
    International journal of oncology, 2001, Volume: 18, Issue:5

    Topics: 1-Methyl-3-isobutylxanthine; Bucladesine; Cell Division; Colforsin; Cyclic AMP; Dihydrotestosterone; Dose-Response Relationship, Drug; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Messenger; Tumor Cells, Cultured

2001
Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype.
    Biochimica et biophysica acta, 2001, May-28, Volume: 1539, Issue:1-2

    Topics: Androgens; Bucladesine; Carcinoma; Cell Differentiation; Culture Media; Humans; Hydroxamic Acids; Interleukin-6; Male; Neurosecretory Systems; Phenotype; Phosphopyruvate Hydratase; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Tyrosine Phosphatases; Receptor-Like Protein Tyrosine Phosphatases, Class 4; Receptors, Androgen; Receptors, Cell Surface; Staining and Labeling; Tumor Cells, Cultured

2001
Proline-rich tyrosine kinase 2 regulates proliferation and differentiation of prostate cells.
    Molecular and cellular endocrinology, 2002, Jan-15, Volume: 186, Issue:1

    Topics: Bucladesine; Cell Differentiation; Cell Division; Enzyme Activation; Epithelial Cells; Focal Adhesion Kinase 2; Humans; Lysophospholipids; Male; Prostatic Neoplasms; Protein-Tyrosine Kinases; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2002
Transcriptional regulation of androgen receptor gene expression in Sertoli cells and other cell types.
    Molecular and cellular endocrinology, 1992, Volume: 88, Issue:1-3

    Topics: Animals; Bucladesine; Cells, Cultured; Follicle Stimulating Hormone; Gene Expression Regulation; Humans; Lymphatic Metastasis; Male; Metribolone; Muscle, Smooth; Prostatic Neoplasms; Rats; Receptors, Androgen; Recombinant Fusion Proteins; RNA, Messenger; Sertoli Cells; Testis; Transcription, Genetic; Transfection; Tumor Cells, Cultured

1992
Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.
    Proceedings of the National Academy of Sciences of the United States of America, 1992, Apr-15, Volume: 89, Issue:8

    Topics: 1-Methyl-3-isobutylxanthine; Aprotinin; Blotting, Northern; Bucladesine; Cell Division; Cell Line; Cyclic AMP; Cycloheximide; Dactinomycin; DNA Replication; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Leupeptins; Male; Pentoxifylline; Phenylmethylsulfonyl Fluoride; Prostatic Neoplasms; RNA, Neoplasm; Theophylline; Transcription, Genetic; Transforming Growth Factor beta; Tumor Cells, Cultured

1992
Role of cyclic AMP and polypeptide growth regulators in growth inhibition by interferon in PC-3 cells.
    The Prostate, 1991, Volume: 18, Issue:1

    Topics: Alprostadil; Bucladesine; Cyclic AMP; Epidermal Growth Factor; Fibroblast Growth Factors; Growth Substances; Humans; Interferon Type I; Male; Platelet-Derived Growth Factor; Prostatic Neoplasms; Transforming Growth Factors; Tumor Cells, Cultured

1991